Novel PCSK9 Inhibitors for Treating Cardiovascular Diseases.
Rachel MataPublished in: ACS medicinal chemistry letters (2024)
Provided herein are novel PCSK9 inhibitors, pharmaceutical compositions, use of such compounds in treating cardiovascular diseases, and processes for preparing such compounds.